再生障碍性贫血临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 再生障碍性贫血（国际通用名 aplastic anemia）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖再障等说法。

正在招募的再生障碍性贫血新药试验

• T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias

  I 期 / II 期招募中美国NCT03653338

• Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS)

  不适用招募中美国NCT07186179

• A Study of Emapalumab for Pediatric Aplastic Anemia

  II 期招募中美国NCT06430788

• Revolade Tablets Specified Drug-use Survey

  不适用招募中日本NCT06287268

• Two Step Haplo With Radiation Conditioning

  II 期招募中美国NCT05031897

• AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion

  II 期招募中美国NCT04099966

• Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

  I 期 / II 期招募中德国西班牙NCT06648096

• Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

  早期 I 期招募中美国NCT06398457

• National Registry of Rare Kidney Diseases

  不适用招募中英国NCT06065852

• Umbilical Cord Blood Transplantation From Unrelated Donors

  不适用招募中美国NCT03016806

• Role of Acetaldehyde in the Development of Oral Cancer

  不适用招募中美国NCT05973656

• Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab

  I 期 / II 期招募中美国NCT04784052